Treatment for Pneumocystis jirovecii infection in immunocompromised patients includes TMP-SMX or Pentamidine, with Dapsone and Atovaquone for prophylaxis or treatment. Prophylaxis starts at CD count <200 in HIV patients.
El tratamiento para la infección por Pneumocystis jirovecii en pacientes inmunocomprometidos incluye TMP-SMX o pentamidina, con dapsone y atovaquona para profilaxis o tratamiento. La profilaxis se inicia con un recuento CD <200 en VIH.
| Front | What are the treatment guidelines for pneumocystic jirovecii infection in an immunocompromised patient? |
|---|---|
| Back | TMP-SMX or Pentamidine (if pt has a sulfa allergy) Dapsone → prophylaxis as monotherapy or treatment in tandem with TMP Atovaquone Start prophylaxis at CD count < 200 cells/mm3 in HIV pts |
Tags: antifungal, drugs
Learn with these flashcards. Click next, previous, or up to navigate to more flashcards for this subject.
Next card: Conditions treated tmp-smx combination combination used for following uti shigella
Previous card: Toxoplasmosis sulfadiazine pyrimethamine treatment disease brain abscesses immunocompromised
Up to card list: Microbiology 101 → Step 1 USMLE